Method for protein analysis

Patent metadata

Field	Value
Publication number	US-9983203-B2
Application number	US-201515108505-A
Country	US
Kind code	B2
Filing date	Feb 12, 2015
Priority date	Feb 13, 2014
Publication date	May 29, 2018
Grant date	May 29, 2018

Abstract

Provided are methods for protein analysis in which proteins to be analyzed are displayed on a population of discrete and dispersible structures, such as beads or other particles, for subsequent affinity reactions and analysis/detection. The proteins to be analyzed may be provided as denatured protein samples in the presence of a denaturing agent.

First claim

The invention claimed is:

1. A method for protein analysis comprising providing a denatured protein sample in the presence of a denaturing agent, the method comprising the following steps;
a) contacting said denatured protein sample with a population of protein-binding structures to capture a plurality of different proteins on said structures, wherein said structures are discrete and dispersible,
b) removing the denaturing agent to display protein- and protein-feature specific epitopes from said sample on said structures;
c) performing affinity probing targeted to a sub-group of said protein or protein feature specific epitopes requiring two or more specificity building events per targeted protein or protein feature with affinity probes comprising an oligonucleotide, thereby resulting in a target specific nucleic acid molecule or sequence for each of the targeted proteins or protein-features;
d) liberating said protein- or protein-feature specific nucleic acid sequences from said structures;
e) optionally amplifying said nucleic acid sequences;
f) analysing the nucleic acid molecules by a quantitative and sequence specific nucleic acid detection method; and
g) determining therefrom the quantity or presence of targeted proteins or protein features in said sample.

2. The method according to claim 1 , wherein the protein binding structures are selected from the groups of microparticles, nanoparticles, nanofibers, and combinations thereof.

3. The method according to claim 2 , wherein the protein binding structures are selected from porous or non-porous structures of natural or synthetic polymers, ceramic structures, metallic structures, and combinations thereof.

4. The method according to claim 3 , wherein the protein binding structure is a paramagnetic agarose bead.

5. The method according to claim 1 , wherein the protein binding structures in the population all have identical binding specificities.

6. The method according to claim 1 , wherein the protein binding structures collectively have multiple binding specificities.

7. The method according to claim 6 , wherein multiple proteins or protein features are targeted by affinity probing and nucleic acid detection to generate a multiplex determination of quantity or presence of said proteins or protein features simultaneously.

8. The method according to claim 7 , wherein the proteins in said denatured protein sample have been conjugated to a hapten and said protein binding structures contain an affinity ligand directed against the hapten.

9. The method according to claim 8 , wherein the hapten is biotin and the affinity ligand is streptavidin or avidin.

10. The method according to claim 9 , wherein unreacted excess hapten reagents are reduced or removed following conjugation and prior to contacting the sample with protein binding structures.

11. The method according to claim 1 , wherein said protein binding structures are chemically activated and contacting said sample results in covalent coupling of proteins to the structures.

12. The method according to claim 11 , wherein said protein binding structures are NHS activated.

13. The method according to claim 1 , wherein the protein denaturing agent is selected from the group consisting of sodium dodecyl sulfate, lithium dodecyl sulfate, Urea, Thio-Urea, and Guanidine-HCl.

14. The method according to claim 13 , wherein the provided denatured protein sample resulted from heating a protein sample to above 80° C. in the presence of a denaturing agent from said group.

15. The method according to claim 13 , wherein the SDS concentration in said sample is reduced to a range of 0.1-0.3% prior to step a) contacting the denatured protein sample with protein binding structures, wherein the method further comprises the steps of:
(i) contacting the denatured protein sample with porous lid beads designed with a hydrophilic surface layer allowing only low molecular weight molecules to enter the inner pore volume which is modified with octylamine ligands having affinity for SDS;
(ii) allowing SDS to accumulate within the lid beads for a defined time period; and
(iii) removing the lid beads from the denatured protein sample of step (i).

16. The method according to claim 1 , further comprising the steps of:
(i) following capture on the protein binding structures in step a),
(ii) the population of structures are isolated and re-suspended in a stability promoting storage solution,
(iii) and before b) and c) the structures are isolated from the storage solution and re-suspended in a buffer suitable for affinity probing.

17. The method according to claim 1 , wherein the affinity probing comprises the following steps:
(i) contacting the structures with captured proteins with one or multiple aptamers each having been selected for having high affinity and slow-off rate for a single protein- or protein feature specific epitope;
(ii) isolating the structures after having allowed time for protein-aptamer binding;
(iii) re-suspending the structures in a solution containing poly-anions to promote a differential release of non-specifically bound aptamers enabled by the slow off-rate of the specific interaction;
(iv) isolating the structures; and
(v) re-suspending the structures in a solution and treating them to promote elution of the aptamers still bound after the poly-anion treatment.

18. The method according to claim 1 , wherein the affinity probing employs affinity binders coupled to oligonucleotides and results in target specific nucleic acid molecules as a result of a combination of proximal binding of two or more affinity binders carrying different oligonucleotides to the same protein or protein-feature target and the action of nucleic acid processing enzymes added during the probing.

19. The method according to claim 18 , further comprising the steps of:
(i) using rolling circle amplification reactions to create DNA-spheres consisting of condensed linear repeats of protein or protein feature specific nucleic acid molecules;
(ii) hybridizing the DNA spheres with labelled detection oligonucleotides specific for each protein or protein feature specific DNA sphere; and
(iii) detecting a signal proportional to the number of DNA spheres present.

20. The method according to claim 19 , wherein the DNA spheres are fluorescently labelled and digitally counted in a flow system.

21. The method according to claim 19 , wherein the DNA spheres are labelled by magnetic nanoparticles and detected using magnetorelaxometry.

22. The method according to claim 18 , wherein the affinity probing employs proximity extension reactions or proximity ligation reactions.

23. The method according to claim 1 , wherein quantitative PCR, an oligonucleotide array or a sequencing procedure allowing counting individual sequence readings is used as the nucleic acid detection method.

Assignees

• Ge Healthcare Bio Sciences Ab

Inventors

• Ivansson Daniel
• Estmer Nilsson Camilla
• Graner Therese
• Ohman Johan

Classifications

• G01N2333/79

  Transferrins, e.g. lactoferrins, ovotransferrins · CPC title

• G01N33/6803

  General methods of protein analysis not limited to specific proteins or families of proteins · CPC title

• G01N2458/10

  Oligonucleotides as tagging agents for labelling antibodies · CPC title

• G01N33/54353

  with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title

• C12Q1/6804

  Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title